Sermorelin Nasal Spray — Natural Growth Hormone Stimulation
Compounded Sermorelin Nasal Spray is a growth hormone-releasing hormone (GHRH) analogue that stimulates the pituitary to produce growth hormone naturally — supporting body composition, energy, sleep quality, and healthy aging without direct GH administration.
Sermorelin (GHRH Analogue)
A synthetic analogue of endogenous growth hormone-releasing hormone (GHRH), specifically the first 29 amino acids responsible for full biological activity. Sermorelin stimulates pituitary somatotrophs to synthesize and release growth hormone, preserving the natural pulsatile GH secretion pattern and pituitary feedback regulation rather than suppressing the axis.
Why Sermorelin vs. Direct GH?
Unlike direct recombinant HGH (rhGH), sermorelin maintains hypothalamic-pituitary feedback regulation, reducing the risk of GH-related side effects from excess levels. It avoids pituitary axis suppression seen with exogenous GH, supports physiologically appropriate pulsatile release, and is considered to have a more favorable safety profile for long-term hormone optimization use.
| Typical Timing | Common Dose Range | Frequency | Route |
|---|---|---|---|
| 30–45 min before bedtime | 200–400 mcg (individualized) | Daily (nightly) or per prescriber | Intranasal |
Timing: Administer 30–45 minutes before bedtime to align with the body's natural peak growth hormone release during slow-wave sleep. Evening dosing also minimizes daytime side effects.
Cycle Protocol: Commonly prescribed for 3–6 month cycles with a rest period of 1 month to prevent tachyphylaxis and maintain pituitary responsiveness. Long-term protocols vary by clinician.
Lab Monitoring: Prescribers typically obtain baseline and follow-up IGF-1 levels to assess response and guide dose titration. Glucose and fasting insulin levels should be monitored in patients with metabolic concerns.
All dosing must be initiated and managed by the prescribing provider. Genesis does not adjust doses independently.
Sermorelin is a GHRH receptor agonist. Its mechanism proceeds through:
- Pituitary Stimulation: Binds GHRH receptors on pituitary somatotroph cells, triggering calcium influx and cyclic AMP accumulation to stimulate GH synthesis and release.
- IGF-1 Upregulation: Released GH travels to the liver and stimulates synthesis and secretion of Insulin-like Growth Factor-1 (IGF-1), the primary mediator of anabolic growth hormone effects — protein synthesis, lipolysis, lean mass support.
- Natural Pulsatility: Sermorelin preserves the natural pulsatile pattern of GH secretion (largest pulse during slow-wave sleep), unlike continuous exogenous GH administration which blunts the pituitary axis.
- Hypothalamic-Pituitary Feedback: Somatostatin and endogenous IGF-1 still exert negative feedback — acting as a natural safety limit preventing excessive GH levels.
With intranasal delivery, sermorelin is absorbed via nasal mucosa, offering a needle-free alternative to the traditional subcutaneous injection while maintaining clinical efficacy as a secretagogue.
FDA-Approved Indication (historical): Diagnosis of growth hormone deficiency in children (sermorelin acetate injection; original brand Geref®; no longer commercially manufactured).
Common Off-Label / Anti-Aging Uses:
- Growth Hormone Deficiency (Adult): Stimulates endogenous GH in patients with reduced GH secretion due to aging or pituitary insufficiency.
- Body Composition: May support lean muscle mass and reduce body fat through IGF-1-mediated protein synthesis and lipolysis.
- Energy & Stamina: Many patients report improved energy, physical endurance, and exercise recovery over the course of treatment.
- Sleep Quality: GH secretagogues administered at bedtime may enhance slow-wave sleep architecture, addressing the GH-sleep cycle.
- Skin & Connective Tissue: GH/IGF-1 axis supports collagen and elastin synthesis; some patients report improved skin texture and reduced age-related changes.
- Cognitive Function: Some evidence for GH axis role in memory and executive function; under investigation.
Sermorelin nasal spray is off-label. Benefits are based on the known physiology of GH/IGF-1 signaling and clinical experience with sermorelin secretagogue therapy. Not FDA-approved for these indications in adults.
Contraindications:
- Active malignancy — growth factors can stimulate tumor growth; GH secretagogues are contraindicated until malignancy is in remission
- Hypothyroidism (untreated) — uncontrolled hypothyroidism blunts GH response; normalize thyroid function before initiating
- Known hypersensitivity to sermorelin or formulation excipients
- Pregnancy or nursing — safety not established; avoid use
- Severe pituitary pathology — pituitary adenoma, radiation-damaged pituitary; evaluate with endocrinologist first
Common Side Effects:
- Nasal discomfort — mild irritation, congestion, or rhinorrhea with intranasal route
- Headache — typically transient; resolves with dose reduction
- Flushing
- Dizziness
- Nausea (uncommon)
- Transient fluid retention (water retention/edema at higher doses)
- Carpal tunnel symptoms (typically with excessive GH elevation)
Monitoring Considerations:
- IGF-1 at baseline and every 3 months to ensure levels are within physiologic range
- Fasting glucose and insulin in patients with metabolic syndrome or pre-diabetes
- Thyroid function prior to initiation
- Refrigerate at 2°C to 8°C (36°F to 46°F)
- Do not freeze; discard if frozen
- Protect from light
- Discard after the beyond-use date on the label
- Keep out of reach of children
- The medicine should be fine for 5 days from the shipping date at temperatures up to 105 degrees Fahrenheit.
How is sermorelin different from injecting human growth hormone (HGH)?
Sermorelin stimulates your own pituitary gland to produce and release GH naturally — it does not add exogenous HGH. This preserves the body's normal feedback regulation and pulsatile GH release pattern, significantly reducing the risk of side effects from GH excess seen with direct HGH injections.
When will I notice results?
Initial effects (sleep quality, energy) may appear within 2–4 weeks. Body composition changes typically become noticeable after 2–3 months of consistent use. IGF-1 levels are measured to confirm physiological response.
Why take it at night?
The body's largest natural GH pulse occurs during the first few hours of deep (slow-wave) sleep. Taking sermorelin at bedtime amplifies this natural pulse, maximizing therapeutic benefit while aligning with circadian biology.
How long should I use it?
Most protocols run 3–6 months with a 1-month rest period to prevent pituitary desensitization (tachyphylaxis). Long-term maintenance protocols are determined by your prescriber based on IGF-1 monitoring and clinical response.
Can sermorelin help with weight loss?
Sermorelin may support fat reduction as a secondary benefit through IGF-1-mediated lipolysis, particularly when combined with appropriate nutrition and exercise. It is not a primary weight-loss therapy.
Is it safe with testosterone replacement therapy (TRT)?
Sermorelin is commonly used alongside TRT and is generally considered compatible. Discuss your full medication list with your prescriber for individualized guidance.
Partner with Genesis Compounding
A 503A-licensed compounding partner built for telehealth and physician practice workflows. Download your onboarding documents below to get started.
Fax completed forms to 385-855-1221 or email pharmacy@genesiscompounding.com